Abstract: There is provided pharmaceutical compounds of formula I, wherein R1, R2, R3, R4, R6, X, Y, Z, Y1, Y2, Y3 and Y4 have meanings given in the description, which compounds are useful in the treatment of autoimmune and/or fibrotic diseases, including interstitial lung diseases, such as idiopathic pulmonary fibrosis and sarcoidosis.

Abstract: The present invention concerns a low-emissive paint comprising metal particles, a binder and a solvent. The metal particles consist of a metal with lower electro-negativity than 1.9 but higher than 1.1 or a mixture of such metals, and the binder consists of polyaniline—PANI—or a polymer where a thiophene group is included in the chain.

Abstract: The present invention concerns a low-emissive paint comprising metal particles, a binder and a solvent. The metal particles consist of a metal with lower electro-negativity than 1.9 but higher than 1.1 or a mixture of such metals, and the binder consists of polyaniline—PANI—or a polymer where a thiophene group is included in the chain.

Abstract: The concentration of oxygen clusters in silicon is determined with a spectrometer, for the infrared interval, by obtaining the absorption coefficients for one or more of the wave numbers 728.+-.1, 734.+-.1, 975.+-.1, 988.+-.1, 1000.+-.1, 1006.+-.1 and 1012.+-.1.sup.cm-1, using the standard method that is used to determine oxygen atoms in interstitial position and carbon atoms in substitutional position when the measurement is carried out at the wave number 1106 and 605 cm.sup.-1. The absorption measurements are taken at room temperature and are standardized with respect to the thickness of the sample. The measurements are multiplied with a known calibration constant, whereupon the respective absorption coefficient for the different measured wave numbers are a measure of the concentration of different configurations of the oxygen clusters.